Kimberly-Clark Corporation


Want a discount? Become a member by purchasing Annual Subscription!
SKU: KMB Category:


The consumer-staples giant, Kimberly-Clark continues to witness a downward trajectory after a thoroughly mediocre result. The management cited the reason behind the weak performance to be supply chain disruption, faster than expected consumer tissue destocking, and a sharp rise in input costs. Also, an increase in other manufacturing costs like costs arising from COVID-19 and inefficiencies from lower production volumes coupled with unfavorable foreign currency rates caused the downside. Nevertheless, the company remains focused to execute its K-C Strategy 2022 and is inclined to reinforce its overall market position. Moreover, a rise in net selling prices and savings of $65 million from the FORCE (Focused On Reducing Costs Everywhere) program and $40 million from the 2018 Global Restructuring Program acts as some bright points. We maintain our ‘Hold’ rating on the stock.

Our Report Structure:

⦁ Company Overview
⦁ Investment Thesis
⦁ Key Drivers
⦁ Historical Quarterly Statement Analysis – Income Statement & Cash Flows
⦁ Historical Quarterly Balance Sheet Analysis
⦁ Historical Annual Financial Statement Analysis
⦁ Analysis Of Key Financial Ratios
⦁ Financial Forecasts For 3 Years
⦁ Forecasting The Capital Structure & Net Debt
⦁ Discounted Cash Flow Valuation
⦁ Trading Multiples
⦁ Key Risks
⦁ Disclosures

Want unlimited access to our reports? Purchase our $496 annual subscription!